Document is current

Article History

Received: 2 January 2024

Accepted: 15 January 2024

First Online: 20 February 2024

Declarations

:

: CT has received funds for speaking at symposia organized on behalf of Pfizer, Novartis, Merck, Angelini, Zambon, Thermo Fisher, Biotest, Gilead, Hikma, Biomerieux and Astellas. RI is employee of Pfizer and may hold Pfizer stock or stock options. DD has received payments or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from the following commercial sources: Allergan, Amgen, Astellas, Eli Lilly, Janssen Cilag, Nestle´ HS, Novartis, Novo Nordisk, Pfizer, Servier, Takeda. None of the other authors have any conflicts of interest to declare.

: This study did not require an institutional review board oversight due to its retrospective nature and the anonymity of pooled data.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.